Gonadotropin-releasing hormone analogues for palliation of carcinoma of the prostate

@article{Wenderoth2004GonadotropinreleasingHA,
  title={Gonadotropin-releasing hormone analogues for palliation of carcinoma of the prostate},
  author={U. Wenderoth and G. Jacobi},
  journal={World Journal of Urology},
  year={2004},
  volume={1},
  pages={40-48}
}
SummarySince the introduction of contrasexual treatment as the basic concept of palliation of prostatic carcinoma in the 1940's, orchiectomy, estrogens, and, in recent years, antiandrogens have become generally accepted treatment forms. Three facts: 1) estrogen treatment being at best palliative and at worst dangerous; 2) surgical castration having psychological impacts, at least in the younger age group; and 3) both being probably ineffective from the beginning, have led us to investigate an… Expand
Buserelin in the treatment of prostatic cancer.
  • F. Roila
  • Medicine
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  • 1989
Is disease flare a problem?
Treatment of prostatic cancer. Newer forms of androgen deprivation.
...
1
2
...

References

SHOWING 1-10 OF 42 REFERENCES
Hormonal Therapy of Prostatic Cancer
Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases.
Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
...
1
2
3
4
5
...